Company Filing History:
Years Active: 1999
Title: Innovations of Chung Ha Choi in Antitumor Agents
Introduction
Chung Ha Choi is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of two patents to his name, his work is recognized for its potential impact on cancer treatment.
Latest Patents
Choi's latest patents focus on arylsulfonylimidazolone derivatives as antitumor agents. These novel compounds demonstrate superior antineoplastic activity compared to known sulfonylurea antitumor agents, while also exhibiting minimal side effects. The specific formula and its pharmaceutically acceptable salts and stereoisomers are detailed in his patent specifications.
Career Highlights
Choi is currently associated with Dongwha Pharm. Ind. Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for cancer, showcasing his dedication to improving patient outcomes.
Collaborations
Choi collaborates with esteemed colleagues such as Sung June Yoon and Yong Ho Chung. Their combined expertise contributes to the advancement of research and development in the field of oncology.
Conclusion
Chung Ha Choi's contributions to the development of antitumor agents highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to pave the way for new treatments that may significantly benefit cancer patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.